Public Health

1066 readers
25 users here now

For issues concerning:

🩺 This community has a broader scope so please feel free to discuss. When it may not be clear, leave a comment talking about why something is important.

Related Communities

See the pinned post in the Medical Community Hub for links and descriptions. link ([email protected])

Rules

Given the inherent intersection that these topics have with politics, we encourage thoughtful discussions while also adhering to the mander.xyz instance guidelines.

Try to focus on the scientific aspects and refrain from making overly partisan or inflammatory content

Our aim is to foster a respectful environment where we can delve into the scientific foundations of these topics. Thank you!

founded 2 years ago
MODERATORS
[email protected]
[email protected]
listing: all - local
751
1
Time to scale up testing and treatment for HBV and HCV in the WHO Eastern Mediterranean Region (www.thelancet.com)
submitted 2 years ago* (last edited 2 years ago) by [email protected] to c/[email protected]
0 comments fedilink
 
 

The 2021 WHO global progress report on HIV, viral hepatitis, and sexually transmitted infections estimated that globally, 354 million people were living with chronic HBV or HCV infection in 2019, causing 1·11 million deaths. In WHO's Eastern Mediterranean Region (EMR), 18 million people were living with chronic HBV infection and 12 million with chronic HCV infection, causing 63 000 deaths. The Global Burden of Disease estimated that in 2019, in the EMR, hepatitis B and C were responsible for 3·4 million disability-adjusted life-years lost and caused chronic liver diseases, including cancers and cirrhosis, in 35 million people. This morbidity and mortality is preventable.